Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Bladder transitional cell carcinoma stage III+2

Not recruiting

Registered drugNo placebo

Long-Term Study for Cancer Patients Using Atezolizumab Therapy

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Squamous cell carcinoma of lung+3

Not recruiting

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Sotorasib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug

Hungary

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Registered drugNo placebo

Hungary

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deutivacaftor

Contact Research Centre

Small cell lung cancer extensive stage

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Irinotecan

Contact Research Centre

Non-small cell lung cancer stage III

Not recruiting

Registered drugNo placebo

Study of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 5

68 trials match your criteria

Bladder transitional cell carcinoma stage III+2

Long-Term Study for Cancer Patients Using Atezolizumab Therapy

Squamous cell carcinoma of lung+3

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

Non-small cell lung cancer

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations

Non-small cell lung cancer

Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy

Non-small cell lung cancer+2

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Non-small cell lung cancer

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Non-small cell lung cancer

Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Cystic fibrosis

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Small cell lung cancer extensive stage

Study of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer

Small cell lung cancer

Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer

Non-small cell lung cancer stage III

Study of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.